Ibrutinib ‐induced rapid response in chemotherapy‐refractory Richter's syndrome
Hematological Oncology,Volume 36, Issue 1, Page 370-371, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 6, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 262-268, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 6, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 202-209, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 6, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 370-371, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 6, 2017 Category: Hematology Source Type: research
Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan
In conclusion, this study confirmed that cigarette smoking increases the risk of AML in Japanese. This study provides important evidence that smoking increases the risk of AML among Asians, which has already been shown in Western populations. (Source: Hematological Oncology)
Source: Hematological Oncology - July 6, 2017 Category: Hematology Authors: Tomotaka Ugai, Keitaro Matsuo, Isao Oze, Hidemi Ito, Kenji Wakai, Keiko Wada, Chisato Nagata, Tomio Nakayama, Rong Liu, Yuri Kitamura, Akiko Tamakoshi, Ichiro Tsuji, Yumi Sugawara, Norie Sawada, Atsuko Sadakane, Keitaro Tanaka, Tetsuya Mizoue, Manami Inou Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study)
Abstract
Complete response (CR) after treatment for multiple myeloma is associated with superior progression‐free survival (PFS). Multiple myeloma patients were prospectively recruited for induction treatment with bortezomib and dexamethasone (BD) followed by autologous hematopoietic cell transplantation (auto‐HCT) between 2010 and 2012. If patients did not achieve CR after auto‐HCT, BD consolidation therapy was added to target CR.
After the BD induction phase (n = 46), greater than or equal to CR was achieved in 4 patients (8%). After auto‐HCT (n = 34), greater than or equal to CR was achieved in 9 patients (2...
Source: Hematological Oncology - July 6, 2017 Category: Hematology Authors: Hideki Nakasone, Kiriko Terasako ‐Saito, Teiichi Hirano, Atsushi Wake, Seiichi Shimizu, Naoki Kurita, Etsuko Yamazaki, Kensuke Usuki, Kohei Akazawa, Junya Kanda, Koichiro Minauchi, Go Yamamoto, Shiori Tanimoto, Masaharu Kamoshita, Yasuhisa Yokoyama, Ets Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Intensive induction chemotherapy vs hypomethylating agent –based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - June 30, 2017 Category: Hematology Source Type: research
Partial deletion of the ALK gene in ALK ‐positive anaplastic large cell lymphoma
Hematological Oncology,Volume 36, Issue 1, Page 150-158, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 30, 2017 Category: Hematology Source Type: research
---
Hematological Oncology, Ahead of Print. (Source: Hematological Oncology)
Source: Hematological Oncology - June 30, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 150-158, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 30, 2017 Category: Hematology Source Type: research
Partial deletion of the ALK gene in ALK ‐positive anaplastic large cell lymphoma
Abstract
Anaplastic lymphoma kinase (ALK) protein is an orphan receptor tyrosine kinase that is constitutively activated by aberrant translocations of the ALK gene in anaplastic large cell lymphoma, ALK‐positive and several other cancers. Additionally, aberrant mutation and amplification of the ALK gene, resulting in ALK kinase activation, were detected mainly in neuroblastoma. Recently, truncated ALK protein was also reported in neuroblastoma. Here, we describe a novel truncated form of the ALK transcript with in‐frame skipping through exons 2 to 17 (ALKΔ2‐17) in anaplastic large cell lymphoma, ALK‐positive. The ...
Source: Hematological Oncology - June 30, 2017 Category: Hematology Authors: Suguru Fukuhara, Junko Nomoto, Sung ‐Won Kim, Hirokazu Taniguchi, Akiko Miyagi Maeshima, Kensei Tobinai, Yukio Kobayashi Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
Hematological Oncology, EarlyView. (Source: Hematological Oncology)
Source: Hematological Oncology - June 29, 2017 Category: Hematology Source Type: research
---
Hematological Oncology, Ahead of Print. (Source: Hematological Oncology)
Source: Hematological Oncology - June 29, 2017 Category: Hematology Source Type: research
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry
Hematological Oncology,Volume 36, Issue 1, Page 189-195, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 23, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 189-195, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 23, 2017 Category: Hematology Source Type: research
